
Neurogene Inc. – NASDAQ:NGNE
Neurogene stock price today
Neurogene stock price monthly change
Neurogene stock price quarterly change
Neurogene key metrics
Market Cap | 461.61M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -2.83 |
Revenue | N/A |
EBITDA | -69.61M |
Income | -48.80M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNeurogene stock price history
Neurogene stock forecast
Neurogene financial statements
$52
Potential upside: 163.95%
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 0 | -11.86M | |
---|---|---|---|
Sep 2023 | 0 | -4.52M | |
Dec 2023 | 0 | -15.50M | |
Mar 2024 | 0 | -16.92M |
Jun 2023 | 85794000 | 254.84M | 297.05% |
---|---|---|---|
Sep 2023 | 89586000 | 14.35M | 16.02% |
Dec 2023 | 222573000 | 36.54M | 16.42% |
Mar 2024 | 195350000 | 24.57M | 12.58% |
Jun 2023 | -4.10M | -374.61K | -295.27K |
---|---|---|---|
Sep 2023 | -4.29M | -1.61M | -1.24K |
Dec 2023 | -29.51M | 16.68M | 92.00M |
Mar 2024 | -21.65M | 29.93M | -6.52M |
Neurogene alternative data
Feb 2024 | 82 |
---|---|
Mar 2024 | 91 |
Apr 2024 | 91 |
Jun 2024 | 91 |
Jul 2024 | 91 |
Neurogene other data
Period | Buy | Sel |
---|---|---|
Nov 2024 | 120270 | 0 |
-
What's the price of Neurogene stock today?
One share of Neurogene stock can currently be purchased for approximately $19.7.
-
When is Neurogene's next earnings date?
Unfortunately, Neurogene's (NGNE) next earnings date is currently unknown.
-
Does Neurogene pay dividends?
No, Neurogene does not pay dividends.
-
How much money does Neurogene make?
Neurogene has a market capitalization of 461.61M.
-
What is Neurogene's stock symbol?
Neurogene Inc. is traded on the NASDAQ under the ticker symbol "NGNE".
-
What is Neurogene's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Neurogene?
Shares of Neurogene can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Neurogene have?
As Jul 2024, Neurogene employs 91 workers.
-
When Neurogene went public?
Neurogene Inc. is publicly traded company for more then 11 years since IPO on 7 Mar 2014.
-
What is Neurogene's official website?
The official website for Neurogene is neurogene.com.
-
Where are Neurogene's headquarters?
Neurogene is headquartered at 535 W 24th Street, New York, NY.
-
How can i contact Neurogene?
Neurogene's mailing address is 535 W 24th Street, New York, NY and company can be reached via phone at (877) 237-5020.
-
What is Neurogene stock forecast & price target?
Based on 3 Wall Street analysts` predicted price targets for Neurogene in the last 12 months, the avarage price target is $52. The average price target represents a 163.95% change from the last price of $19.7.
Neurogene company profile:

Neurogene Inc.
neurogene.comNASDAQ
91
Biotechnology
Healthcare
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease. The company is headquartered in New York, New York.
New York, NY 10011
CIK: 0001404644
ISIN: US64135M1053
CUSIP: 64135M105